2012
Ghazi A, Scosyrev E, Patel H, Messing E, Joseph J. "Complications associated with extraperitoneal robot assisted radical prostatectomy using the standardized Martin classification". Urology. 2012; .
|
2012
Scosyrev E. "Identification of causal effects using instrumental variables in randomized trials with stochastic compliance". Biom J. 2012; .
|
2012
Scosyrev E, Tobis S, Donsky H, Wu G, Joseph J, Rashid H, Messing E. "Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies." BJU Int.. 2012; .
|
2012
Scosyrev E. "Interval estimation of treatment effects in randomized trials: when do confidence intervals have nominal coverage?". lnt Statist Rev. 2012; .
|
2012
Tobis S, Venigalla S, Balakumaran K, Scosyrev E, Lloyd GL, Golijanin D, Joseph J, Rashid H, Wu G. "Analysis of a large single-center experience with robot-assisted pyeloplasty". Int J Urol. 2012; .
|
2012
Scosyrev E, Wu G, Mohile S, Messing EM. "Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time". Cancer. 2012; .
|
2012
Scosyrev E, Wu G, Golijanin D, Messing EM. "Prostate-specific antigen testing in older men in the United States: data from the Behavioral Risk Factor Surveillance System". BJU Int.. 2012; .
|
2012
Scosyrev E, Messing EM, Mohile S, Golijanin D, Wu G. "Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality". Cancer. 2012; .
|
2012
Tobis S, Venigalla S, Knopf JK, Scosyrev E, Golijanin D, Erturk E, Joseph JV, Rashid H, Wu G. "Robot-assisted laparoscopic partial nephrectomy: review of the first 100 cases from a single institution". J Robot Surg. 2012; .
|
2012
Gordetsky J, Scosyrev E, Rashid H, Wu G, Silvers C, Golijanin D, Messing EM, Yao J. "Identifying additional lymph nodes in radical cystectomy lymphadenectomy specimens". Mod Pathol. 2012; 25(1):140-44.
|
2012
Scosyrev E, Golijanin D, Wu G, Messing EM. "The burden of bladder cancer in men and women: analysis of the years of life lost". BJU Int. 2012; 109(1):57-62.
|
2012
Scosyrev E, Messing EM, van Wijngaarden E, Peterson DR, Sahasrabudhe D, Golijanin D, and Fisher SG. "Neo-adjuvant gemcitabine-cisplatin chemotherapy for locally advanced urothelial cancer of the bladder". Cancer. 2012; 118(1):72-81.
|
2012
Scosyrev E, Messing J, Noyes K, Veazie P, Messing E. "Surveillance Epidemiology and End Results (SEER) Program and population-based research in urologic oncology: an overview." Urol Oncol.. 2012; 30(2):126-32.
|
2011
Scosyrev E, Wu G, Golijanin D, Messing EM. "Non-bladder cancer mortality in patients with urothelial cancer of the bladder". Urol Oncol. 2011; [Epub ahead of print].
|
2010
Scosyrev E, Ely BW, Messing EM, Speights VO, Grossman HB, Wood DP, de Vere White RW, Vogelzang NJ, Trump DL, Natale RB, Tangen C, Crawford ED, Thompson IM. "Do mixed histological features affect survival benefit from neo-adjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?". BJU Int.. 2010; 108(5):693-699.
|
2010
Scosyrev E, Yao J, Messing E. "Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice". Urology. 2010; 76(4):908-13.
|
2010
Scosyrev E, Trivedi D, Messing E. "Female bladder cancer: incidence, treatment, and outcome." Curr Opin Urol.. 2010; 20:404-408.
|
2009
Scosyrev E, Yao J, Messing E. "Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment?". Urology. 2009; 73(4):822-7.
|
2009
Scosyrev E, Noyes K, Feng C, Messing E. "Sex and racial differences in bladder cancer presentation and mortality in the US". Cancer. 2009; 115(1):68-74.
|
2006
Scosyrev E. "An overview of the human immunodeficiency virus featuring laboratory testing for drug resistance". Clin Lab Sci.. 2006; 19(4):231-45.
|
